MaxCyte, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
MaxCyte, Inc. (MXCT) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 17.70 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13
- MaxCyte, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 17.70M shares, a 9.23% decline year-over-year.
- MaxCyte, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 17.50M shares, a 6.42% decline year-over-year.
- MaxCyte, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 18.10M shares, a 6.47% increase year-over-year.
- MaxCyte, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 19.50M shares, a 12.72% increase year-over-year.
- MaxCyte, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 15.40M shares, a 5.52% decline from fiscal 2024.
- MaxCyte, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 16.30M shares, a 2.40% decline from fiscal 2023.
- MaxCyte, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 16.70M shares, a 11.33% increase from fiscal 2022.
- MaxCyte, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 15.00M shares, a 20.97% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 17.70M shares 10-Q · filed 2026-08-13 | 17.70M shares 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | 17.50M shares 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | 15.40M shares 10-K · filed 2026-03-25 | |||
| 2025-09-30 | 18.10M shares 10-Q · filed 2025-11-13 | 18.10M shares 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | 19.50M shares 10-Q · filed 2026-08-13 | 19.50M shares 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | 18.70M shares 10-Q · filed 2026-05-13 | |||
| 2024-12-31 | 16.30M shares 10-K · filed 2026-03-25 | |||
| 2024-09-30 | 17.00M shares 10-Q · filed 2025-11-13 | 17.00M shares 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | 17.30M shares 10-Q · filed 2025-08-06 | 17.30M shares 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | 17.90M shares 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | 16.70M shares 10-K · filed 2025-03-11 | |||
| 2023-09-30 | 17.10M shares 10-Q · filed 2024-11-06 | 17.10M shares 10-Q · filed 2024-11-06 | ||
| 2023-06-30 | 18.80M shares 10-Q · filed 2024-08-06 | 18.80M shares 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | 17.10M shares 10-Q · filed 2024-05-07 | |||
| 2022-12-31 | 15.00M shares 10-K · filed 2024-03-12 | |||
| 2022-09-30 | 16.10M shares 10-Q · filed 2023-11-08 | 16.10M shares 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | 15.80M shares 10-Q · filed 2023-08-09 | 15.80M shares 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | 15.10M shares 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | 12.40M shares 10-K · filed 2023-03-15 | |||
| 2021-09-30 | 13.00M shares 10-Q · filed 2022-11-09 | 13.00M shares 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | 12.20M shares 10-Q · filed 2022-08-10 | 12.20M shares 10-Q · filed 2022-08-10 | ||
| 2021-03-31 | 12.10M shares 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | 12.90M shares 10-K · filed 2022-03-22 | |||
| 2020-09-30 | 13.00M shares 10-Q · filed 2021-11-10 | 13.00M shares 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | 12.40M shares 10-Q · filed 2021-09-13 | 12.40M shares 10-Q · filed 2021-09-13 | ||
| 2019-12-31 | 10.40M shares 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |